Indiana Hemophilia & Thrombosis Center, Inc.

Indianapolis, IN Part of Innovative Hematology, Inc.

UEI
HN1NK2CMA5Q1
CAGE
5D2T6
Primary NAICS
621112 Offices of Physicians, Mental Health Specialists
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
8326 Naab Rd, Indianapolis, IN 46260, USA
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
Childrens Hospital Medical Center Sickle Cell Treatment Demonstration Program U1E27863 $60,000
Childrens Hospital Medical Center Sickle Cell Treatment Demonstration Program U1EMC27863 $308,000

Similar vendors

Vendor Location Primary NAICS
University Pediatricians UEI V9DWN8CPAVF8 Detroit, MI —
WNY Bloodcare UEI ZFXLTRJP9M98 Buffalo, NY —
Hemophilia Foundation Of Michigan UEI KP3RJLJGJJU5 Ypsilanti, MI 813212 Voluntary Health Organizations
Mary M. Gooley Hemophilia Center, Inc. UEI CLSNE1KYACZ6 Rochester, NY —
Hemophilia Of Georgia UEI MMK8LWAWEW45 Atlanta, GA —

About the company

The Indiana Hemophilia & Thrombosis Center, Inc. (IHTC) is a 501(c)3 nonprofit organization and the only federally recognized comprehensive hemophilia treatment center in Indiana. As one of the largest centers of its kind nationwide, IHTC provides specialized care and support services for individuals with bleeding disorders and related conditions.

IHTC has received prime federal grant funding from agencies like the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA). Its major CDC awards have supported the Indiana Sickle Cell Data Collection Program, aimed at developing systems to track and analyze sickle cell disease data to advance national surveillance and research efforts. As a subawardee, IHTC has collaborated with regional partners such as hemophilia foundations and children's hospitals to improve comprehensive care, participate in quality improvement initiatives, and contribute to national hemophilia patient outcome databases. The center has also worked on projects related to the diagnosis of von Willebrand Disease, participating through subawards from organizations like Versiti Wisconsin, Inc. Additionally, IHTC has been part of the Great Lakes Region Hemophilia Network, supported by HRSA funding, to enhance access to comprehensive care for hemophilia and related disorders in Indiana, Michigan, and Ohio.

Quick answers

Is Indiana Hemophilia & Thrombosis Center, Inc. registered in SAM.gov?

Yes. Indiana Hemophilia & Thrombosis Center, Inc.'s SAM.gov registration is active through April 21, 2027.

What is Indiana Hemophilia & Thrombosis Center, Inc.'s most recent federal award?

Indiana Hemophilia & Thrombosis Center, Inc.'s most recent federal grant award is Indiana sickle cell data collection program (NU58DD000030), from Office of Financial Resources (CDC), on September 30, 2023.

On GovTribe

See Indiana Hemophilia & Thrombosis Center, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors